Derakhshan Behrad Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
7
Insider Sells Sum
$1.77M

Insider Activity of Derakhshan Behrad

According to the SEC Form 4 filings, Derakhshan Behrad, being in a position of

  1. Chief Business Officer at Edgewise Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 5100 shares for $223,424,
    over all time since 2023-05-02, has bought 0 shares, and sold 74815 shares for $2.05M.

Biography of Derakhshan Behrad

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $223,4241100

Comparison of Insiders on Amount of Buys and Sells

2026-08-12SaleEdgewise Therapeutics, Inc.
EWTX
Chief Business Officer
5,100
0.0048%
$43.81$223,424-5.23%
2025-08-12SaleEdgewise Therapeutics, Inc.
EWTX
Chief Business Officer
2,491
0.0024%
$13.39$33,360+118.37%
2025-05-02SaleEdgewise Therapeutics, Inc.
EWTX
Chief Business Officer
1,691
0.0016%
$16.45$27,824+1.27%
2025-02-05SaleEdgewise Therapeutics, Inc.
EWTX
Chief Business Officer
10,000
0.0108%
$30.03$300,300-48.52%
2024-09-20SaleEdgewise Therapeutics, Inc.
EWTX
Chief Business Officer
42,068
0.046%
$29.03$1.22M-17.11%
2024-05-02SaleEdgewise Therapeutics, Inc.
EWTX
Chief Business Officer
1,718
0.0018%
$18.91$32,487+22.94%
2024-02-09SaleEdgewise Therapeutics, Inc.
EWTX
Chief Business Officer
4,800
0.0065%
$20.04$96,209-2.05%
2024-02-08SaleEdgewise Therapeutics, Inc.
EWTX
Chief Business Officer
4,600
0.0063%
$20.01$92,049-3.18%
2024-02-07SaleEdgewise Therapeutics, Inc.
EWTX
Chief Business Officer
600
0.0008%
$20.00$12,000-3.41%
2023-05-02SaleEdgewise Therapeutics, Inc.
EWTX
Chief Business Officer
1,747
0.0028%
$8.90$15,557-7.66%
Total: 10
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.